SLC5A5 and sarcoma: Based on the Jamshidi bone biopsy diagnosis of sarcoma and the likelihood of OSA, the owner elected to enroll the dog in the VIGOR study to receive VSV-IFNβ-NIS in addition to standard of care for OSA.